The PAX8 positivity rates of 0–75% reported earlier for medullary carcinomas of the thyroid may to some extent be caused by PAX8 antibodies cross-reacting with PAX6 [13, 29, 48]. This evidence concerns the gene PAX6 and medullary thyroid gland carcinoma.